What is the risk of venous thromboembolism (VTE) in patients with an intertrochanteric fracture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Risk of VTE After Intertrochanteric Fracture

The risk of venous thromboembolism in patients with intertrochanteric fractures is substantial, with preoperative DVT occurring in 20-43% of patients and postoperative DVT in approximately 25% without prophylaxis, making VTE prophylaxis mandatory for all hip fracture patients.

Incidence Rates

The evidence demonstrates consistently high VTE rates in this population:

  • Preoperative DVT: Ranges from 20.81% 1 to 28.5% 2 to 42.5% 3 depending on the study population and timing of screening
  • Postoperative DVT: 24.88% incidence when prophylaxis protocols vary 4
  • DVT location: The majority (67.6-91.5%) are distal peripheral DVTs 2, 5, though proximal central DVTs occur in approximately 30% of cases

Key Risk Factors

Based on multiple recent studies, the independent risk factors that significantly increase VTE risk include:

Patient Demographics

  • Age >75 years (OR: 1.719) 4 or advanced age as a continuous variable (OR: 1.07 per year) 6
  • Female sex 5
  • BMI >24 (OR: 2.190) 4

Injury and Timing Factors

  • High-energy injury mechanism (OR: 4.184) 4 - this is the strongest predictor
  • Fracture-to-operation time >48 hours (OR: 2.666) 4
  • Prolonged time from injury to admission 5, 1

Comorbidities

  • Diabetes mellitus (OR: 1.511-1.65) 4, 6
  • COPD 1
  • Disseminated cancer (OR: 1.65 for DVT, 2.77 for PE) 7
  • Atrial fibrillation 1

Laboratory Values

  • Elevated D-dimer (>750 ng/ml optimal cutoff, or >6.005 mg/L) 2, 3 - sensitivity 56.52%, specificity 82.35%
  • Low albumin (<36.45-36.6 g/L) 2, 5, 3
  • Low potassium (<3.650 mmol/L) 2
  • Low hemoglobin 1

Operative Factors

  • Longer operative time - each additional 60 minutes increases DVT odds by approximately 19% 7

Clinical Implications and Prophylaxis

Per AAOS guidelines, VTE prophylaxis should be used in all hip fracture patients (moderate strength of evidence, strong strength recommendation) 8. The guideline specifically recommends:

  • Sequential compression devices during hospitalization
  • Pharmacologic prophylaxis (e.g., Lovenox) for 4 weeks postoperatively 8

Critical Pitfalls to Avoid

  1. Don't assume normal initial radiographs rule out DVT - ultrasound screening is essential as 20-43% will have preoperative DVT 2, 5, 1

  2. Don't delay surgery unnecessarily - fracture-to-operation time >48 hours significantly increases DVT risk (OR: 2.666) 4, yet patients need medical optimization

  3. Screen both lower extremities - DVT can occur in the unaffected limb (seen in approximately 15-20% of cases) or bilaterally 5

  4. Don't rely solely on D-dimer - while elevated D-dimer is an independent risk factor, its moderate sensitivity (56.52%) means normal values don't exclude DVT 3

Risk Stratification Algorithm

High-risk patients requiring heightened surveillance include those with:

  • Age >75 years AND
  • High-energy mechanism OR
  • Fracture-to-surgery delay >48 hours OR
  • Disseminated cancer OR
  • D-dimer >750 ng/ml with albumin <36.6 g/L

All patients regardless of risk stratification require:

  • Bilateral lower extremity ultrasound screening on admission
  • Mechanical prophylaxis (sequential compression devices) immediately
  • Pharmacologic prophylaxis for minimum 4 weeks postoperatively 8
  • Early surgery (ideally within 48 hours) when medically optimized

The combination of mechanical and pharmacologic prophylaxis is non-negotiable given the 20-43% baseline preoperative DVT rate and additional postoperative risk 8, 4, 2, 5, 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.